LG Chem to Acquire AVEO Oncology for $15.00 Per Share in Cash
yahoo.com
news
2022-10-18 08:30:00

Acquisition Provides LG Chem's Life Sciences Division a Commercial Footprint in the U.S., Diversifies its Pipeline with a Broad Range of Oncology Therapies and Accelerates LG Chem's Efforts to Deliver Continued Growth

AVEO Will Have Enhanced Ability to Deliver on its Mission to Improve the Lives of Patients with Cancer

AVEO to Establish and Operate as the U.S. Commercial Foundation for LG Chem Life Sciences' Oncology Segment

Transaction Price Represents a 43% Premium to AVEO's Closing Price on October 17, 2022

SEOUL, South Korea and CAMBRIDGE, Mass.
